Gsa Capital Partners LLP Tempest Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2024
A detailed history of Gsa Capital Partners LLP transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 101,043 shares of TPST stock, worth $137,418. This represents 0.02% of its overall portfolio holdings.
Number of Shares
101,043Holding current value
$137,418% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding TPST
# of Institutions
28Shares Held
1.72MCall Options Held
30KPut Options Held
80.5K-
Black Rock Inc. New York, NY550KShares$748,3270.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$239,6220.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$209,7670.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$176,2270.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$143,6160.09% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $14.2M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...